Matinas Biopharma (6LJ0.F) Q4 2024 Earnings

13NovConfirmed
Q3 2024
Q4 2024
-1.14
-1.02
-0.91
-0.8

Details

Expected EPS
-0.9987262999999998
Actual EPS
-0.804661
Surprise EPS
0.19
Surprise Percent
+19.43%

Description

Matinas Biopharma (6LJ0.F) has reported earnings of -0.804661 per share for Q4 2024.

0 Comments

Share your thoughts